These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38076326)

  • 21. A Spatiotemporal Solution to Control COVID-19 Transmission at the Community Scale for Returning to Normalcy: COVID-19 Symptom Onset Risk Spatiotemporal Analysis.
    Tong C; Shi W; Zhang A; Shi Z
    JMIR Public Health Surveill; 2023 Jan; 9():e36538. PubMed ID: 36508488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January-March 2022.
    Mefsin YM; Chen D; Bond HS; Lin Y; Cheung JK; Wong JY; Ali ST; Lau EHY; Wu P; Leung GM; Cowling BJ
    Emerg Infect Dis; 2022 Sep; 28(9):1856-1858. PubMed ID: 35914518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution and Control of COVID-19 Epidemic in Hong Kong.
    Wong SC; Au AK; Lo JY; Ho PL; Hung IF; To KK; Yuen KY; Cheng VC
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing Public Perceptions and Preventive Behaviors During the Early Phase of the COVID-19 Pandemic in Hong Kong and the United Kingdom: Cross-sectional Survey Study.
    Bowman L; Kwok KO; Redd R; Yi Y; Ward H; Wei WI; Atchison C; Wong SY
    J Med Internet Res; 2021 Mar; 23(3):e23231. PubMed ID: 33539309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the impact of rapid antigen tests on SARS-CoV-2 transmission in the fifth wave of COVID-19 in Hong Kong in early 2022.
    Du Z; Tian L; Jin DY
    Emerg Microbes Infect; 2022 Dec; 11(1):1394-1401. PubMed ID: 35536564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic Value of Vaccines to Address the COVID-19 Pandemic in Hong Kong: A Cost-Effectiveness Analysis.
    Xiong X; Li J; Huang B; Tam T; Hong Y; Chong KC; Huo Z
    Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Forecasting of influenza activity and associated hospital admission burden and estimating the impact of COVID-19 pandemic on 2019/20 winter season in Hong Kong.
    Lau YC; Shan S; Wang D; Chen D; Du Z; Lau EHY; He D; Tian L; Wu P; Cowling BJ; Ali ST
    PLoS Comput Biol; 2024 Jul; 20(7):e1012311. PubMed ID: 39083536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multilevel Determinants of COVID-19 Vaccine Uptake Among South Asian Ethnic Minorities in Hong Kong: Cross-sectional Web-Based Survey.
    Singh A; Lai AHY; Wang J; Asim S; Chan PS; Wang Z; Yeoh EK
    JMIR Public Health Surveill; 2021 Nov; 7(11):e31707. PubMed ID: 34653014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment.
    Leung K; Wu JT; Liu D; Leung GM
    Lancet; 2020 Apr; 395(10233):1382-1393. PubMed ID: 32277878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of COVID-19 control measures on respiratory syncytial virus and hand-foot-and-mouth disease transmission in Hong Kong and South Korea.
    Lau YC; Ryu S; Du Z; Wang L; Wu P; Lau EHY; Cowling BJ; Ali ST
    Epidemics; 2024 Dec; 49():100797. PubMed ID: 39426115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infection of healthcare workers despite a high vaccination rate during the fifth wave of COVID-19 due to Omicron variant in Hong Kong.
    Wong SC; Chan VW; Yuen LL; AuYeung CH; Leung JO; Li CK; Kwok MO; So SY; Chen JH; Chiu KH; Tam AR; Hung IF; Kai-Wang To K; Lo JY; Yuen KY; Cheng VC
    Infect Prev Pract; 2023 Mar; 5(1):100261. PubMed ID: 36465098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal resource allocation with spatiotemporal transmission discovery for effective disease control.
    Ren J; Liu M; Liu Y; Liu J
    Infect Dis Poverty; 2022 Mar; 11(1):34. PubMed ID: 35331329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uncovering transmission patterns of COVID-19 outbreaks: A region-wide comprehensive retrospective study in Hong Kong.
    Liu Y; Gu Z; Liu J
    EClinicalMedicine; 2021 Jun; 36():100929. PubMed ID: 34124628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of previous infection-induced and vaccine-induced protection against hospitalisation due to omicron BA subvariants in older adults: a test-negative, case-control study in Quebec, Canada.
    Carazo S; Skowronski DM; Brisson M; Sauvageau C; Brousseau N; Fafard J; Gilca R; Talbot D; Ouakki M; Febriani Y; Deceuninck G; De Wals P; De Serres G
    Lancet Healthy Longev; 2023 Aug; 4(8):e409-e420. PubMed ID: 37459879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of upcoming global infection burden of influenza seasons after relaxation of public health and social measures during the COVID-19 pandemic: a modelling study.
    Ali ST; Lau YC; Shan S; Ryu S; Du Z; Wang L; Xu XK; Chen D; Xiong J; Tae J; Tsang TK; Wu P; Lau EHY; Cowling BJ
    Lancet Glob Health; 2022 Nov; 10(11):e1612-e1622. PubMed ID: 36240828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impacts of social distancing, rapid antigen test and vaccination on the Omicron outbreak during large temperature variations in Hong Kong: A modelling study.
    Yuan HY; Liang J; Hossain MP
    J Infect Public Health; 2022 Dec; 15(12):1427-1435. PubMed ID: 36395667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic use in hospitalized patients with COVID-19: a population-based study in Hong Kong.
    Blais JE; Zhang W; Lin Y; Chui CS; Cheng VC; Cowling BJ; Wu P
    Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e205. PubMed ID: 38028893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 Mortality and Vaccine Coverage - Hong Kong Special Administrative Region, China, January 6, 2022-March 21, 2022.
    Smith DJ; Hakim AJ; Leung GM; Xu W; Schluter WW; Novak RT; Marston B; Hersh BS
    China CDC Wkly; 2022 Apr; 4(14):288-292. PubMed ID: 35433091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population.
    Lau JJ; Cheng SMS; Leung K; Lee CK; Hachim A; Tsang LCH; Yam KWH; Chaothai S; Kwan KKH; Chai ZYH; Lo THK; Mori M; Wu C; Valkenburg SA; Amarasinghe GK; Lau EHY; Hui DSC; Leung GM; Peiris M; Wu JT
    Nat Med; 2023 Feb; 29(2):348-357. PubMed ID: 36652990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case-control study.
    Wan EYF; Mok AHY; Yan VKC; Chan CIY; Wang B; Lai FTT; Chui CSL; Li X; Wong CKH; Lau CS; Wong ICK; Chan EWY
    J Travel Med; 2022 Dec; 29(8):. PubMed ID: 36250571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.